Cover Image
市場調查報告書

兒童癌症:全球臨床實驗趨勢

Pediatric Cancer Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 233621
出版日期 內容資訊 英文 69 Pages
訂單完成後即時交付
價格
Back to Top
兒童癌症:全球臨床實驗趨勢 Pediatric Cancer Global Clinical Trials Review, H2, 2016
出版日期: 2016年10月30日 內容資訊: 英文 69 Pages
簡介

本報告提供全球兒童癌症治療藥臨床實驗相關調查,提供您各地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗等資料。

簡介

  • 兒童癌症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:腫瘤治療藥臨床實驗上兒童癌症的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腫瘤治療藥臨床實驗上兒童癌症的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

兒童癌症治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Zaklad Farmaceutyczny Adamed Pharma S.A.
    • Stemline Therapeutics, Inc.
    • Sanofi
    • OncoTherapy Science, Inc.
    • Grindeks
    • GlaxoSmithKline plc
    • Bristol-Myers Squibb Company
    • Bayer AG
    • Activartis Biotech GmbH
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • University of Texas M. D. Anderson Cancer Center
    • Duke University
    • The University of Hong Kong
    • Erasmus MC
    • The University of Queensland
    • University of Kentucky
    • Karolinska Institute
    • Chinese University of Hong Kong

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3867CTIDB

GlobalData's clinical trial report, "Pediatric Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Pediatric Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pediatric Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Pediatric Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pediatric Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Pediatric Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
  • Source

List of Tables

  • Pediatric Cancer Therapeutics, Global, Clinical Trials by Region, 2016*
  • Pediatric Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Pediatric Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Proportion of Pediatric Cancer to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Pediatric Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Pediatric Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Pediatric Cancer to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Pediatric Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Pediatric Cancer Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Pediatric Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Pediatric Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Pediatric Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Pediatric Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Pediatric Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Pediatric Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Proportion of Pediatric Cancer to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Pediatric Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Pediatric Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Pediatric Cancer to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Pediatric Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Pediatric Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Pediatric Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Pediatric Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Pediatric Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Pediatric Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top